AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29

Authors: Kojima, M Nakagami, H
Citation: M. Kojima et H. Nakagami, Preparation of the controlled-release matrix tablets of theophylline with micronized low-substituted hydroxypropyl cellulose by a fluidized hot-melt granulation method, STP PHARM S, 11(2), 2001, pp. 145-150

Authors: Taniyama, Y Morishita, R Aoki, M Nakagami, H Yamamoto, K Yamazaki, K Matsumoto, K Nakamura, T Kaneda, Y Ogihara, T
Citation: Y. Taniyama et al., Therapeutic angiogenesis induced by human hepatocyte growth factor gene inrat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease, GENE THER, 8(3), 2001, pp. 181-189

Authors: Yoshimura, S Morishita, R Hayashi, K Yamamoto, K Nakagami, H Kaneda, Y Sakai, N Ogihara, T
Citation: S. Yoshimura et al., Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element "decoy' of nuclear factor-kB binding site as a novel molecular strategy, GENE THER, 8(21), 2001, pp. 1635-1642

Authors: Hayashi, K Morishita, R Nakagami, H Yoshimura, S Hara, A Matsumoto, K Nakamura, T Ogihara, T Kaneda, Y Sakai, N
Citation: K. Hayashi et al., Gene therapy for preventing neuronal death using hepatocyte growth factor:in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons, GENE THER, 8(15), 2001, pp. 1167-1173

Authors: Aoki, M Nata, T Morishita, R Matsushita, H Nakagami, H Yamamoto, K Yamazaki, K Nakabayashi, M Ogihara, T Kaneda, Y
Citation: M. Aoki et al., Endothelial apoptosis induced by oxidative stress through activation of NF-kappa B - Antiapoptotic effect of antioxidant agents on endothelial cells, HYPERTENSIO, 38(1), 2001, pp. 48-55

Authors: Yamamoto, K Morishita, R Hayashi, S Matsushita, H Nakagami, H Moriguchi, A Matsumoto, K Nakamura, T Kaneda, Y Ogihara, T
Citation: K. Yamamoto et al., Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions ofhepatocyte growth factor in hypoxia-conditioned human endothelial cells, HYPERTENSIO, 37(5), 2001, pp. 1341-1348

Authors: Nakagami, H Morishita, R Yamamoto, K Taniyama, Y Aoki, M Matsumoto, K Nakamura, T Kaneda, Y Horiuchi, M Ogihara, T
Citation: H. Nakagami et al., Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and Akt in endothelial cells, HYPERTENSIO, 37(2), 2001, pp. 581-586

Authors: Sorrell, DA Menges, M Healy, JMS Deveaux, Y Amano, C Su, Y Nakagami, H Shinmyo, A Doonan, JH Sekine, M Murray, JAH
Citation: Da. Sorrell et al., Cell cycle regulation of cyclin-dependent kinases in tobacco cultivar bright yellow-2 cells, PLANT PHYSL, 126(3), 2001, pp. 1214-1223

Authors: Takemoto, M Node, K Nakagami, H Liao, YL Grimm, M Takemoto, Y Kitakaze, M Liao, JK
Citation: M. Takemoto et al., Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy, J CLIN INV, 108(10), 2001, pp. 1429-1437

Authors: Shiuchi, T Nakagami, H Iwai, M Takeda, Y Cui, TX Chen, R Minokoshi, Y Horiuchi, M
Citation: T. Shiuchi et al., Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle, ENDOCRINOL, 142(2), 2001, pp. 608-612

Authors: Nakagami, H Morishita, R Yamamoto, K Yoshimura, S Taniyama, Y Aoki, M Matsubara, H Kim, S Kaneda, Y Ogihara, T
Citation: H. Nakagami et al., Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells, DIABETES, 50(6), 2001, pp. 1472-1481

Authors: Wu, L Iwai, M Nakagami, H Li, Z Chen, R Suzuki, J Akishita, M de Gasparo, M Horiuchi, M
Citation: L. Wu et al., Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury, CIRCULATION, 104(22), 2001, pp. 2716-2721

Authors: Taniyama, Y Morishita, R Hiraoka, K Aoki, M Nakagami, H Yamasaki, K Matsumoto, K Nakamura, T Kaneda, Y Ogihara, T
Citation: Y. Taniyama et al., Therapeutic angiogenesis induced by human hepatocyte growth factor gene inrat diabetic hind limb ischemia model - Molecular mechanisms of delayed angiogenesis in diabetes, CIRCULATION, 104(19), 2001, pp. 2344-2350

Authors: Cui, TX Nakagami, H Iwai, M Takeda, Y Shiuchi, T Daviet, L Nahmias, C Horiuchi, M
Citation: Tx. Cui et al., Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell, CARDIO RES, 49(4), 2001, pp. 863-871

Authors: Moriguchi, A Nakagami, H Kotani, N Higaki, J Ogihara, T
Citation: A. Moriguchi et al., Contribution of cardiovascular hypersensitivity to orthostatic hypertension and the extreme dipper phenomenon, HYPERTENS R, 23(2), 2000, pp. 119-123

Authors: Nakagami, H Morishita, R Yamamoto, K Taniyama, Y Aoki, M Kim, S Matsumoto, K Nakamura, T Higaki, J Ogihara, T
Citation: H. Nakagami et al., Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells, J HYPERTENS, 18(10), 2000, pp. 1411-1420

Authors: Hayashi, S Morishita, R Matsushita, H Nakagami, H Taniyama, Y Nakamura, T Aoki, M Yamamoto, K Higaki, J Ogihara, T
Citation: S. Hayashi et al., Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21, HYPERTENSIO, 35(1), 2000, pp. 237-243

Authors: Matsushita, H Morishita, R Nata, T Aoki, M Nakagami, H Taniyama, Y Yamamoto, K Higaki, J Yasufumi, K Ogihara, T
Citation: H. Matsushita et al., Hypoxia-induced endothelial apoptosis through nuclear factor-kappa B (NF-kappa B)-mediated bcl-2 suppression - In vivo evidence of the importance of NF-kappa B in endothelial cell regulation, CIRCUL RES, 86(9), 2000, pp. 974-981

Authors: Taniyama, Y Morishita, R Nakagami, H Moriguchi, A Sakonjo, H",Shokei-Kim,"Matsumoto, K Nakamura, T Higaki, J Ogihara, T
Citation: Y. Taniyama et al., Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters, CIRCULATION, 102(2), 2000, pp. 246

Authors: Yamamoto, K Morishita, R Tomita, N Shimozato, T Nakagami, H Kikuchi, A Aoki, M Higaki, J Kaneda, Y Ogihara, T
Citation: K. Yamamoto et al., Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model - Potential application of ribozyme strategy to treat cardiovascular disease, CIRCULATION, 102(11), 2000, pp. 1308-1314

Authors: Matsushita, H Morishita, R Aoki, M Tomita, N Taniyama, Y Nakagami, H Shimozato, T Higaki, J Kaneda, Y Ogihara, T
Citation: H. Matsushita et al., Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells, CIRCULATION, 101(12), 2000, pp. 1447-1452

Authors: Cui, TX Nakagami, H Iwai, M Takeda, Y Shiuchi, T Tamura, K Daviet, L Horiuchi, M
Citation: Tx. Cui et al., ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth, BIOC BIOP R, 279(3), 2000, pp. 938-941

Authors: Nakagami, H Sekine, M Murakami, H Shinmyo, A
Citation: H. Nakagami et al., Tobacco retinoblastoma-related protein phosphorylated by a distinct cyclin-dependent kinase complex with Cdc2/cyclin D in vitro, PLANT J, 18(3), 1999, pp. 243-252

Authors: Nakagami, H Ikeda, U Maeda, Y Yamamoto, K Hojo, Y Kario, K Kuroki, S Shimada, K
Citation: H. Nakagami et al., Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms, J THROMB TH, 8(3), 1999, pp. 191-195

Authors: Vine, E Nakagami, H Murakoshi, C
Citation: E. Vine et al., The evolution of the US energy service company (ESCO) industry: from ESCO to Super ESCO, ENERGY, 24(6), 1999, pp. 479-492
Risultati: 1-25 | 26-29